TriMas Corporation — Q3 2023 Form 10-Q Summary
Reporting period: Quarterly and nine-month periods ended September 30, 2023. Financial statements are unaudited. TriMas designs and manufactures products for consumer products, aerospace and defense, and industrial markets through its Packaging, Aerospace, and Specialty Products segments.
Financial Performance and Position
| Metric | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
|---|---|---|---|---|
| Net sales | $235.3 million | $218.5 million | $684.0 million | $680.5 million |
| Gross profit | $55.9 million | $48.3 million | $158.2 million | $162.7 million |
| Gross margin | 23.8% | 22.1% | 23.1% | 23.9% |
| Operating profit | $23.8 million | $21.0 million | $53.8 million | $72.8 million |
| Operating margin | 10.1% | 9.6% | 7.9% | 10.7% |
| Net income | $16.5 million | $13.3 million | $32.4 million | $47.3 million |
| Diluted EPS | $0.40 | $0.32 | $0.78 | $1.11 |
Cash flow and liquidity: Nine-month operating cash flow was $57.6 million versus $46.6 million in the prior-year period. Capital expenditures were $34.9 million, and acquisitions used $77.3 million. Financing cash outflows were $23.2 million, including $13.4 million of share repurchases and $5.0 million of dividends. Cash and cash equivalents declined to $34.7 million from $112.1 million at December 31, 2022.
Debt: Long-term debt was $395.4 million, consisting primarily of $400.0 million of 4.125% senior notes due April 2029. The company had no revolving-credit borrowings, $293.7 million of stated availability, and $277.7 million of borrowing capacity available for general corporate purposes after leverage restrictions. Actual total net leverage was 2.32x versus a 4.00x covenant limit; interest coverage was 12.29x versus a 3.00x minimum. The company was in compliance with its financial covenants.
Balance sheet: Total assets were $1.342 billion and shareholders’ equity was $675.0 million at September 30, 2023. Receivables increased to $165.8 million and inventories to $182.3 million from year-end levels.
Material Changes Versus Prior Comparable Period
- Q3 sales increased 7.7%, driven by Aarts and Weldmac acquisitions, aerospace demand, and Specialty Products growth. Organic sales excluding acquisitions and currency declined $1.2 million.
- Nine-month sales increased only 0.5%; acquisition growth and Aerospace and Specialty Products gains were largely offset by a substantial Packaging decline.
- Packaging weakened: Q3 sales declined 10.2% and nine-month sales declined 16.0%, reflecting customer inventory reductions, lower closure and dispenser demand, and cautious consumer-related ordering.
- Aerospace improved: Q3 sales increased 48.8% and nine-month sales increased 29.2%, supported by aircraft-build demand, market-share gains, improved throughput, and Weldmac.
- Specialty Products improved: Q3 sales increased 18.1% and nine-month sales increased 23.6%, with higher demand for cylinders, engines, compressors, and related products.
- Q3 gross and operating margins improved year over year, but nine-month margins declined because of lower Packaging volume, lower fixed-cost absorption, realignment charges, increased professional fees, and the absence of the $4.8 million land-sale gain recorded in Q3 2022.
- Corporate expenses increased to $37.9 million for the nine months, including higher professional fees, centralized information-technology costs, employee costs, and stock compensation.
Outlook, Commentary, Risks, and Unusual Items
- Management expects macroeconomic and global-market uncertainty to persist through the remainder of 2023 and into 2024, with volatile customer ordering, input-cost inflation, supply-chain constraints, and labor availability issues.
- Aerospace order intake remains strong; management expects to increase capacity and address manufacturing-throughput constraints.
- Packaging is expected to experience a longer and more gradual recovery because of continuing uncertainty around consumer sentiment and customer inventory levels. Specialty Products sales are expected to moderate from current high levels.
- Management expects sufficient liquidity and covenant headroom for debt service, capital expenditures, dividends, share repurchases, and bolt-on acquisitions for the foreseeable future, but this is subject to operating performance and market conditions.
- 2023 realignment charges were $2.7 million in Q3 and $6.4 million for the nine months, primarily related to consolidating facilities in China and Rohnert Park, California.
- Weldmac generated $9.7 million of Q3 sales and resulted in a $1.2 million non-cash purchase-accounting inventory charge. Remaining contingent consideration may be up to $4.5 million; management believed the maximum was probable at September 30.
- The effective tax rate declined to 16.3% in Q3 and 23.1% for the nine months, partly because of a $2.4 million tax benefit related to foreign tax-loss carryforwards.
- Asbestos litigation involved 459 pending cases covering 4,860 claimants. The asbestos-related liability was $27.3 million. Management does not believe the matters will materially affect financial position, results, or cash flow, but acknowledges potential for additional claims and costs.
- Key risks include customer concentration, cyclical demand, commodity and energy costs, supply-chain and labor disruptions, foreign-exchange and interest-rate exposure, leverage, acquisitions and integration, goodwill or intangible-asset impairment, cybersecurity, geopolitical conditions, litigation, and environmental or regulatory changes.
Investor Verification Items
- Verify whether Packaging demand and customer inventory normalization improve, and whether the expected recovery timeline extends beyond management’s current outlook.
- Monitor Aerospace capacity expansion, manufacturing throughput, Weldmac integration, and the sustainability of recent order growth.
- Reconcile cash usage from acquisitions, capital expenditures, working capital, dividends, and repurchases against the $34.7 million cash balance and available revolver capacity.
- Track leverage, interest expense, variable-rate exposure, covenant headroom, and the April 2029 senior-note maturity.
- Assess the recurring versus nonrecurring impact of realignment charges, purchase-accounting adjustments, professional fees, centralized information-technology costs, and the lower tax rate.
- Review asbestos claims, actuarial assumptions, insurance coverage availability, and the $27.3 million recorded liability.
- Confirm subsequent dividend payments and future share repurchases, which remain subject to board approval, liquidity, market conditions, and debt-agreement restrictions.